David Shelton

919 total citations
27 papers, 662 citations indexed

About

David Shelton is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David Shelton has authored 27 papers receiving a total of 662 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Surgery and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David Shelton's work include Cervical Cancer and HPV Research (4 papers), Ovarian cancer diagnosis and treatment (4 papers) and RNA modifications and cancer (4 papers). David Shelton is often cited by papers focused on Cervical Cancer and HPV Research (4 papers), Ovarian cancer diagnosis and treatment (4 papers) and RNA modifications and cancer (4 papers). David Shelton collaborates with scholars based in United Kingdom, United States and Israel. David Shelton's co-authors include Deborah L. Gumucio, J L Slightom, Todd A. Gray, Susan A. Tarlé, D. N. Rana, FS Collins, Danilo A. Tagle, M. Goodman, M Goodman and Wendy J. Bailey and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

David Shelton

26 papers receiving 648 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Shelton United Kingdom 12 413 124 99 88 74 27 662
Zuoming Deng United States 13 550 1.3× 88 0.7× 157 1.6× 22 0.3× 49 0.7× 26 760
Enrica Rampazzo Italy 13 234 0.6× 58 0.5× 91 0.9× 12 0.1× 172 2.3× 18 689
Gönül Oğur Türkiye 13 468 1.1× 93 0.8× 210 2.1× 40 0.5× 27 0.4× 51 700
Timothy Hong United States 7 280 0.7× 272 2.2× 36 0.4× 179 2.0× 182 2.5× 20 785
Ana Alfonso Piérola Spain 13 323 0.8× 63 0.5× 264 2.7× 73 0.8× 140 1.9× 50 839
Simon McBride United Kingdom 5 310 0.8× 26 0.2× 230 2.3× 20 0.2× 148 2.0× 9 635
D. Anderson United States 7 237 0.6× 16 0.1× 58 0.6× 46 0.5× 92 1.2× 8 445
Ana Paula Martins Sebastião Brazil 14 118 0.3× 108 0.9× 23 0.2× 14 0.2× 133 1.8× 43 492
Xuexi Yang China 18 452 1.1× 74 0.6× 185 1.9× 32 0.4× 98 1.3× 95 862
F. H. Herrmann Germany 14 299 0.7× 21 0.2× 90 0.9× 62 0.7× 12 0.2× 50 866

Countries citing papers authored by David Shelton

Since Specialization
Citations

This map shows the geographic impact of David Shelton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Shelton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Shelton more than expected).

Fields of papers citing papers by David Shelton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Shelton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Shelton. The network helps show where David Shelton may publish in the future.

Co-authorship network of co-authors of David Shelton

This figure shows the co-authorship network connecting the top 25 collaborators of David Shelton. A scholar is included among the top collaborators of David Shelton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Shelton. David Shelton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Bailey, Simon, et al.. (2022). Fast investigative lung cancer pathway and endobronchial ultrasound procedure supported by rapid on‐site evaluation. Diagnostic Cytopathology. 50(9). 436–441. 4 indexed citations
3.
Wallace, Andrew J., Simon Bailey, Muhammad Qasim, et al.. (2021). Validation of ROS1 by immunohistochemistry against fluorescent in situ hybridisation on cytology and small biopsy samples in a large teaching hospital. Cytopathology. 32(5). 621–630. 5 indexed citations
4.
O’Flynn, Helena, et al.. (2021). Diagnostic accuracy of cytology for the detection of endometrial cancer in urine and vaginal samples. Nature Communications. 12(1). 952–952. 45 indexed citations
6.
Rana, D. N., David Shelton, Helena O’Flynn, et al.. (2021). Synchronous uterine and bladder cancers detected in urine and vaginal samples by cytology. Diagnostic Cytopathology. 50(3). E86–E91. 5 indexed citations
7.
Thiryayi, S. A., et al.. (2018). A retrospective 3‐year study of salivary gland FNAC with categorisation using the Milan reporting system. Cytopathology. 29(4). 343–348. 59 indexed citations
9.
Farooq, Vasim, Patrick W. Serruys, Mamas A. Mamas, et al.. (2016). Forward and back aspiration during ST-elevation myocardial infarction: a feasibility study. EuroIntervention. 11(14). e1639–e1648. 9 indexed citations
10.
Shelton, David, et al.. (2013). Modeling and simulation of patient admission services in a multi-specialty outpatient clinic. Winter Simulation Conference. 2309–2319. 6 indexed citations
11.
Shelton, David, et al.. (2013). Modeling and simulation of patient admission services in a multi-specialty outpatient clinic. 2013 Winter Simulations Conference (WSC). 2309–2319. 11 indexed citations
12.
Shelton, David, et al.. (2011). Adenosquamous carcinoma of the lung diagnosed by cytology?: A diagnostic dilemma. Diagnostic Cytopathology. 40(9). 830–833. 7 indexed citations
13.
Shelton, David, Paul K. Wright, Iskander H. Chaudhry, & Alan Curry. (2009). A persistent scalp nodule caused by the human botfly: exoskeletal larval spines are a key diagnostic feature of myiasis. Histopathology. 54(6). 751–752. 1 indexed citations
14.
Eyden, Brian, et al.. (2009). An EMA negative, desmin positive malignant mesothelioma: limitations of immunohistochemistry?. Journal of Clinical Pathology. 62(7). 651–652. 6 indexed citations
15.
Shelton, David, Lauren D. Stegman, Ross C. Hardison, et al.. (1997). Phylogenetic Footprinting of Hypersensitive Site 3 of the β-Globin Locus Control Region. Blood. 89(9). 3457–3469. 28 indexed citations
16.
Livneh, Avi, Joost P.H. Drenth, Ina S. Klasen, et al.. (1997). Familial Mediterranean fever and hyperimmunoglobulinemia D syndrome: two diseases with distinct clinical, serologic, and genetic features.. PubMed. 24(8). 1558–63. 34 indexed citations
17.
Gumucio, Deborah L., David Shelton, Wei Zhu, et al.. (1996). Evolutionary Strategies for the Elucidation ofcisandtransFactors That Regulate the Developmental Switching Programs of the β-like Globin Genes. Molecular Phylogenetics and Evolution. 5(1). 18–32. 57 indexed citations
18.
Shen, Yang, Leonid Kruglyak, Ivona Aksentijevich, et al.. (1996). Linkage disequilibrium mapping places the gene causing familial Mediterranean fever close to D16S246.. PubMed. 58(3). 523–34. 23 indexed citations
19.
Gumucio, Deborah L., Todd A. Gray, Susan A. Tarlé, et al.. (1992). Phylogenetic Footprinting Reveals a Nuclear Protein Which Binds to Silencer Sequences in the Human y and e Globin Genes. Molecular and Cellular Biology. 12(11). 4919–4929. 44 indexed citations
20.
Maybaum, Jonathan, Eric Burton, David Shelton, et al.. (1991). Divergent patterns of incorporation of bromodeoxyuridine and iododeoxyuridine in human colorectal tumor cell lines. Biochemical Pharmacology. 42(1). 131–137. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026